UBS O'Connor’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100,317
Closed -$590K 487
2025
Q2
$590K Sell
100,317
-47,378
-32% -$309K 0.02% 264
2025
Q1
$1.24M Sell
147,695
-126,505
-46% -$1.14M 0.03% 165
2024
Q4
$2.04M Buy
274,200
+56,445
+26% +$378K 0.05% 154
2024
Q3
$1.26M Buy
217,755
+4,779
+2% +$30.7K 0.03% 249
2024
Q2
$1.42M Buy
212,976
+77,063
+57% +$623K 0.04% 246
2024
Q1
$1.77M Sell
135,913
-19,000
-12% -$253K 0.05% 194
2023
Q4
$1.98M Sell
154,913
-18,091
-10% -$183K 0.06% 173
2023
Q3
$2.27M Buy
173,004
+60,551
+54% +$1.11M 0.04% 224
2023
Q2
$2.88M Sell
112,453
-33,106
-23% -$854K 0.06% 200
2023
Q1
$3.67M Buy
+145,559
New +$3.42M 0.09% 184
2022
Q4
Sell
-132,637
Closed -$2.93M 332
2022
Q3
$2.93M Sell
132,637
-6,000
-4% -$116K 0.03% 440
2022
Q2
$1.99M Buy
+138,637
New +$2.34M 0.02% 657

Other funds holding TMCI